407 related articles for article (PubMed ID: 15814836)
21. Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis.
Reynolds J; Norgan VA; Bhambra U; Smith J; Cook HT; Pusey CD
J Am Soc Nephrol; 2002 Feb; 13(2):359-369. PubMed ID: 11805163
[TBL] [Abstract][Full Text] [Related]
22. Immunodominant epitopes of alpha3(IV)NC1 induce autoimmune glomerulonephritis in rats.
Chen L; Hellmark T; Wieslander J; Bolton WK
Kidney Int; 2003 Dec; 64(6):2108-20. PubMed ID: 14633133
[TBL] [Abstract][Full Text] [Related]
23. Anti-GBM glomerulonephritis: a T cell-mediated autoimmune disease?
Lou YH
Arch Immunol Ther Exp (Warsz); 2004; 52(2):96-103. PubMed ID: 15179323
[TBL] [Abstract][Full Text] [Related]
24. Synthetic peptides of Goodpasture's antigen in antiglomerular basement membrane nephritis in rats.
Luo AM; Fox JW; Chen L; Bolton WK
J Lab Clin Med; 2002 May; 139(5):303-10. PubMed ID: 12032491
[TBL] [Abstract][Full Text] [Related]
25. The pathogenicity of T cell epitopes on human Goodpasture antigen and its critical amino acid motif.
Hu SY; Gu QH; Wang J; Wang M; Jia XY; Cui Z; Zhao MH
J Cell Mol Med; 2017 Sep; 21(9):2117-2128. PubMed ID: 28296059
[TBL] [Abstract][Full Text] [Related]
26. High nephritogenicity of monoclonal antibodies belonging to IgG2a and IgG2b subclasses in rat anti-GBM nephritis.
Kohda T; Okada S; Hayashi A; Kanzaki S; Ninomiya Y; Taki M; Sado Y
Kidney Int; 2004 Jul; 66(1):177-86. PubMed ID: 15200424
[TBL] [Abstract][Full Text] [Related]
27. The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity.
Zhao J; Yan Y; Cui Z; Yang R; Zhao MH
Hum Immunol; 2009 Jun; 70(6):425-9. PubMed ID: 19364515
[TBL] [Abstract][Full Text] [Related]
28. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease.
Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145
[TBL] [Abstract][Full Text] [Related]
29. Molecular mapping of the Goodpasture's epitope for glomerulonephritis.
Bolton WK; Chen L; Hellmark T; Fox J; Wieslander J
Trans Am Clin Climatol Assoc; 2005; 116():229-36; discussion 237-8. PubMed ID: 16555617
[TBL] [Abstract][Full Text] [Related]
30. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells.
Ooi JD; Holdsworth SR; Kitching AR
J Autoimmun; 2008 Nov; 31(3):295-300. PubMed ID: 18502098
[TBL] [Abstract][Full Text] [Related]
31. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
[TBL] [Abstract][Full Text] [Related]
32. Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by 'autoantigen complementarity'.
Reynolds J; Preston GA; Pressler BM; Hewins P; Brown M; Roth A; Alderman E; Bunch D; Jennette JC; Cook HT; Falk RJ; Pusey CD
J Autoimmun; 2015 May; 59():8-18. PubMed ID: 25841937
[TBL] [Abstract][Full Text] [Related]
33. T-cell epitope of alpha3 chain of type IV collagen induces severe glomerulonephritis.
Wu J; Borillo J; Glass WF; Hicks J; Ou CN; Lou YH
Kidney Int; 2003 Oct; 64(4):1292-301. PubMed ID: 12969147
[TBL] [Abstract][Full Text] [Related]
34. Point mutations of single amino acids abolish ability of alpha3 NC1 domain to elicit experimental autoimmune glomerulonephritis in rats.
Hellmark T; Chen L; Ohlsson S; Wieslander J; Bolton WK
J Biol Chem; 2003 Nov; 278(47):46516-22. PubMed ID: 12970356
[TBL] [Abstract][Full Text] [Related]
35. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
36. The role of T-helper lymphocytes in priming for experimental autoimmune glomerulonephritis in the BN rat.
Reynolds J; Sallie BA; Syrganis C; Pusey CD
J Autoimmun; 1993 Oct; 6(5):571-85. PubMed ID: 8240662
[TBL] [Abstract][Full Text] [Related]
37. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
Ryan JJ; Mason PJ; Pusey CD; Turner N
Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978
[TBL] [Abstract][Full Text] [Related]
38. Experimental autoimmune Goodpasture's disease: a pathogenetic role for both effector cells and antibody in injury.
Dean EG; Wilson GR; Li M; Edgtton KL; O'Sullivan KM; Hudson BG; Holdsworth SR; Kitching AR
Kidney Int; 2005 Feb; 67(2):566-75. PubMed ID: 15673304
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical characterization of glomerular inflammatory cells and expression of adhesion molecules in anti-glomerular basement membrane (anti-GBM) glomerulonephritis induced in WKY rats with monoclonal anti-GBM antibodies of different subclasses.
Kado T; Kohda T; Okada S; Hayashi A; Utsunomiya Y; Kanzaki S; Sado Y; Yamamoto T
Pathol Int; 2006 Feb; 56(2):55-61. PubMed ID: 16445816
[TBL] [Abstract][Full Text] [Related]
40. TH1 and TH17 cells promote crescent formation in experimental autoimmune glomerulonephritis.
Hünemörder S; Treder J; Ahrens S; Schumacher V; Paust HJ; Menter T; Matthys P; Kamradt T; Meyer-Schwesinger C; Panzer U; Hopfer H; Mittrücker HW
J Pathol; 2015 Sep; 237(1):62-71. PubMed ID: 25965582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
